DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia (English)
- New search for: Lencz, T.
- New search for: Robinson, D.G.
- New search for: Napolitano, B.
- New search for: Sevy, S.
- New search for: Kane, J.M.
- New search for: Goldman, D.
- New search for: Malhotra, A.K.
- New search for: Lencz, T.
- New search for: Robinson, D.G.
- New search for: Napolitano, B.
- New search for: Sevy, S.
- New search for: Kane, J.M.
- New search for: Goldman, D.
- New search for: Malhotra, A.K.
In:
PHARMACOGENETICS AND GENOMICS
;
20
, 9
;
569-572
;
2010
-
ISSN:
- Article (Journal) / Print
-
Title:DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
-
Contributors:Lencz, T. ( author ) / Robinson, D.G. ( author ) / Napolitano, B. ( author ) / Sevy, S. ( author ) / Kane, J.M. ( author ) / Goldman, D. ( author ) / Malhotra, A.K. ( author )
-
Published in:PHARMACOGENETICS AND GENOMICS ; 20, 9 ; 569-572
-
Publisher:
- New search for: WILKINS
-
Place of publication:LIPPINCOTT WILLIAMS &
-
Publication date:2010-01-01
-
Size:4 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.7
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 615.7 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 20, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 525
-
Effects of the CYP3A5^*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysisTang, H.-L. / Ma, L.-L. / Xie, H.-G. / Zhang, T. / Hu, Y.-F. et al. | 2010
- 532
-
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedemaWoodard-Grice, A.V. / Lucisano, A.C. / Byrd, J.B. / Stone, E.R. / Simmons, W.H. / Brown, N.J. et al. | 2010
- 537
-
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetilGensburger, O. / Van Schaik, R.H.N. / Picard, N. / Le Meur, Y. / Rousseau, A. / Woillard, J.-B. / Van Gelder, T. / Marquet, P. et al. | 2010
- 544
-
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary interventionBeijk, M.A.M. / Boekholdt, S.M. / Rittersma, S.Z.H. / Pons, D. / Zwinderman, A.H. / Doevendans, P.A.F. / Tio, R.A. / Tijssen, J.G.P. / Jukema, J.W. / de Winter, R.J. et al. | 2010
- 553
-
The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanolDowning, C. / Marks, M.J. / Larson, C. / Johnson, T.E. et al. | 2010
- 565
-
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen responseKiyotani, K. / Mushiroda, T. / Hosono, N. / Tsunoda, T. / Kubo, M. / Aki, F. / Okazaki, Y. / Hirata, K. / Takatsuka, Y. / Okazaki, M. et al. | 2010
- 569
-
DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophreniaLencz, T. / Robinson, D.G. / Napolitano, B. / Sevy, S. / Kane, J.M. / Goldman, D. / Malhotra, A.K. et al. | 2010
- 573
-
Thiopurine pathwayZaza, G. / Cheok, M. / Krynetskaia, N. / Thorn, C. / Stocco, G. / Hebert, J.M. / McLeod, H. / Weinshilboum, R.M. / Relling, M.V. / Evans, W.E. et al. | 2010